SCHEMBL6155413

SCHEMBL6155413

CC(CCCC(=O)O)c1cccc(COc2ccc(C(C)(C)O[SiH2]C(C)(C)C)c(C(C)(C)O[SiH2]C(C)(C)C)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 1/20 0.47
CYSLTR1 Q9Y271 1/20 0.47
FFAR1 O14842 10/20 0.40
MRGPRX4 Q96LA9 2/20 0.38
FFAR4 Q5NUL3 3/20 0.36
AKR1B1 P15121 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6155769 0.90 CYSLTR2 (0.35) CYSLTR2CYSLTR1FFAR1MRGPRX4KMT2A
SCHEMBL6154987 0.85 PTGER3 (0.34) CYSLTR2CYSLTR1FFAR1MRGPRX4
SCHEMBL6156494 0.79 FFAR1 (0.48) CYSLTR2CYSLTR1FFAR1FFAR4AKR1B1
SCHEMBL6155257 0.76 MAOB (0.52) MRGPRX4SMN1; SMN2
SCHEMBL6155407 0.74 CYSLTR2 (0.49) CYSLTR2CYSLTR1FFAR1MRGPRX4FFAR4
SCHEMBL6155136 0.74 FFAR1 (0.38) CYSLTR2CYSLTR1FFAR1
SCHEMBL6158473 0.69 CYP4F2 (0.38) FFAR1
SCHEMBL2107789 0.68 MRGPRX4 (0.44) CYSLTR2CYSLTR1FFAR1MRGPRX4
SCHEMBL2107787 0.68 VDR (0.40) CYSLTR2CYSLTR1FFAR1MRGPRX4
SCHEMBL13978185 0.67 MAOB (0.52) MRGPRX4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1124779-B1 VITAMIN D ANALOGUES GALDERMA RES & DEV (FR) 2005-02-02 EP disclosed
EP-1124779-A1 VITAMIN D ANALOGUES Galderma Research & Development, S.N.C. (FR) 2001-08-22 EP disclosed
WO-2000026167-A1 VITAMIN D ANALOGUES GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2000-05-11 WO disclosed